"Cardiovascular Imaging and Biomarker Analyses (CIBER)" is a single-center, prospective and observational study evaluating the expression of novel biomarkers in patients undergoing cardiacvascular imaging within clinical routine care. It is aimed to evaluate associations with biomarker expressions with ascertained cardiac imaging parameters.
"Cardiovascular Imaging and Biomarker Analyses (CIBER)" is a single-center, prospective and observational study evaluating the expression of novel biomarkers in patients undergoing cardiacvascular imaging within clinical routine care. It is aimed to evaluate associations with biomarker expressions with ascertained cardiac imaging parameters. Furthermore the prognostic value of biomarkers and imaging parameters on mid-term and long-term prognosis will be evaluated. Novel biomarkers will comprise blood derived biomarkers including neurohormones, proteins, cytokines, microRNAs and metabolomics.
Study Type
OBSERVATIONAL
Enrollment
500
Patients are undergoing echocardiography
Patients are undergoing magnetic resonance imaging
Patients are undergoing computed tomography
First Department of Medicine, University Medical Centre Mannheim
Mannheim, Germany
Biomarker levels before cardiac imaging
Time frame: 24 hours before cardiac imaging
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Peripheral blood samples are being collected from all patients